Last reviewed · How we verify
Cryoablation
At a glance
| Generic name | Cryoablation |
|---|---|
| Sponsor | University of Minnesota |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer (PHASE2)
- Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients (NA)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
- CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer. (NA)
- Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation (NA)
- Cryoablation vs Thoracoscopic Surgery for GGN (NA)
- Endoscopic and Cryoablation Denervation for Sacroiliac Joint Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cryoablation CI brief — competitive landscape report
- Cryoablation updates RSS · CI watch RSS
- University of Minnesota portfolio CI